Full-Time

Senior Principal

Lean Deployment

Deadline 11/24/27
Waters Corporation

Waters Corporation

10,001+ employees

Analytical instruments, software, and services provider

No salary listed

Franklin, MA, USA

In Person

Category
Operations & Logistics (1)
Required Skills
Six Sigma
Visio
Requirements
  • Ten or more years of progressive experience in a manufacturing environment
  • Bachelor’s degree is required; Advanced degree preferred
  • Ability to engage leaders and shop floor employees in deploying lean methodologies
  • A track record of sustainable results
  • Prior knowledge and practical experience in a manufacturing/industrial setting with a strong focus on Lean Manufacturing operations
  • Experience in deploying a Lean Operating System in a manufacturing environment achieving breakthrough results in safety, quality, productivity, and supply agility
  • Experience with end-to-end value stream improvement with tools including, SMED, 6S, Visual Management, Daily Management, standard work, etc. (preferred)
  • Lean/Six-Sigma Black Belt certification or equivalent qualification (preferred)
  • Strong leadership skills, self-directed and the ability to make independent decisions; Bias towards action
  • Capable of positively influencing people at all levels in the organization
  • Competent in the use of advanced statistical and six-sigma techniques (preferred)
  • PMP certification or equivalent project management training and experience (preferred)
  • Experience with Visio and Microsoft Office applications
  • Excellent organizational, interpersonal, verbal, written, and presentation skills
  • Ability to define problems, collect data, establish facts, and drive improvements
  • Strong facilitation and coaching skills
Responsibilities
  • Partner with the site leadership team to develop and execute the plan for continuous improvement within the overall framework of our Lean Operating System and deployment roadmap
  • Lead focused transformation efforts in key areas of the site(s)
  • Apply Structured Problem Solving and/or Value Stream Mapping to facilitate and lead groups through analysis, improvement planning, and implementation
  • Improve/install tiered visual and daily management reporting systems to enable effective management of the factory
  • Charter, plan, and facilitate kaizen events to drive immediate, sustainable improvements on the shop floor
  • Analyze and improve transaction-based processes to identify sources of waste and productivity improvements for increased efficiency and cost savings
  • Deliver formal and informal training on key Lean and CI tools including Daily Management, Problem Solving, 6S, Setup reduction, Kanban, OEE, and line efficiency
  • Coach, build, and grow the skills and capabilities of others in Lean methods and Continuous Improvement
  • Challenge current thinking to drive a higher level of sustainable results
  • Demonstrate knowledge sharing (leading practices, benchmarking) from across Waters and outside of the organization
  • Drive targeted, sustainable improvement in SQDCP (Safety, Quality, Delivery, Cost, and Productivity) that is tied to company objectives
  • Support opportunities at other sites or outside manufacturing as appropriate
Desired Qualifications
  • Advanced degree (Master’s or higher) preferred
  • Lean/Six-Sigma Black Belt certification or equivalent qualification (preferred)
  • Experience with end-to-end value stream improvement with tools including SMED, 6S, Visual Management, Daily Management, standard work, etc. (preferred)
  • PMP certification or equivalent project management training and experience (preferred)
  • Experience with Visio and Microsoft Office applications (preferred)

Waters Corporation provides analytical system solutions, software, and services for scientists across biopharma, clinical research, forensics, life science research, food and beverage, and environmental sectors. Its products include high-performance analytical instruments like the BioAccord System, paired with software and ongoing support to enable precise, reproducible results. The company operates by selling instruments and software and offering maintenance and services to enhance user experience and reliability. Compared to competitors, Waters offers an integrated package of hardware, software, and service across multiple markets, focused on delivering accurate analyses and end-to-end workflow solutions rather than just standalone devices. Its goal is to unlock the potential of science by solving problems that affect human health and well-being.

Company Size

10,001+

Company Stage

IPO

Headquarters

Milford, Connecticut

Founded

1958

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 organic growth 11% constant currency; raised full-year guidance to 6.5-8%.
  • Acquired BD Biosciences unit exceeded revenue by $40M; targeting $55M cost synergies.
  • China pharmaceutical revenue grew 50%+ targeting biotech CDMOs and emerging domestic companies.

What critics are saying

  • Competitors release comparable MALS and blood culture systems within 12-18 months, eroding differentiation.
  • $3.5B debt at 4.3-5.2% creates refinancing cliff 2027-2036 if growth slows.
  • BD acquisition integration risks $55M synergy target; supply chain fragmentation could halve realized savings.

What makes Waters Corporation unique

  • BD BACTEC FXI detects bloodstream infections 3 hours faster with automated blood volume measurement.
  • omniDAWN MALS enables 4x faster large molecule analysis with 10x molar mass improvement.
  • ARES-G3 Rheometer reduces testing times 80% while capturing 25,000 data points per second.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

PR Newswire
Apr 14th, 2026
Waters launches omniDAWN MALS detector for UHPLC, enabling 4x faster analysis of large molecules

Waters Corporation has launched the omniDAWN Multi-Angle Light Scattering Photometer, the first extended-range MALS detector designed for ultra high performance liquid chromatography workflows. The device features 18 detection angles and delivers chromatographic run times up to four times faster than conventional methods. The photometer extends UPLC-compatible sizing tenfold, from approximately 50 to 500 nanometres in radius, enabling characterisation of complex molecules including protein aggregates, viral vectors and lipid nanoparticles. It achieves a 10-fold improvement in absolute molar mass measurements whilst reducing sample consumption by 30–50% and solvent use by roughly 40%. The device integrates with Waters UPLC systems and is powered by ASTRA software, supporting analysis across drug discovery, development and quality control. The omniDAWN photometer will be available globally in summer 2026.

PR Newswire
Apr 8th, 2026
Waters gains FDA clearance for at-home cervical cancer screening kit with HPV assay

Waters Corporation has received FDA clearance for the Onclarity HPV Self-Collection Kit and approval for the BD Onclarity HPV Assay with extended genotyping for at-home use. The kit enables cervical cancer screening from home, addressing barriers that prevent many individuals from routine testing. Approximately 60% of cervical cancer cases occur in unscreened or under-screened individuals. The BD Onclarity HPV Assay is the only FDA-approved test identifying six individual HPV genotypes and three pooled groups, making it the most comprehensive screening tool available in the US. The kit will be available by prescription in coming months and is covered by private insurance, Medicaid and Medicare. Waters is establishing partnerships for broader nationwide access, with patients able to collect samples at home and mail them to laboratories for processing.

Paul Hastings LLP
Mar 23rd, 2026
Waters Corporation subsidiary raises $3.5B through senior notes offering

Paul Hastings advised underwriters including Barclays Capital, Citigroup Global Markets and J.P. Morgan Securities in a $3.5 billion senior notes offering by Augusta SpinCo Corporation, a Waters Corporation subsidiary. The SEC-registered offering comprises five tranches of senior notes maturing between 2027 and 2036, with interest rates ranging from 4.321% to 5.245%. The notes are guaranteed by Waters and certain subsidiaries. Partner Jeff Ramsay led the Paul Hastings team, which included partners Morgan Bale, Ismael Duran and Daniel Nicholas, along with several associates.

Yahoo Finance
Mar 19th, 2026
Waters Corporation stock down 22.8% year-on-year, underperforming Dow's 11.2% rise

Waters Corporation (WAT), a leading scientific instruments manufacturer, is underperforming the Dow Jones Industrial Average significantly. The stock trades 28.8% below its 52-week high of $414.15 and has declined 22.3% year-to-date, compared to the Dow's 3.8% decline. The Milford, Massachusetts-based company, with a market cap of $28.9 billion, specialises in analytical technologies including liquid chromatography and mass spectrometry for pharmaceutical, life sciences and industrial applications. Despite reporting solid fourth-quarter results with revenue of $932 million, up 7% year-over-year, and adjusted earnings per share rising 10% to $4.53, investor sentiment has soured. Cautious first-quarter guidance and concerns over its acquisition of Becton Dickinson's biosciences unit, which is underperforming expectations, have weighed on the stock.

Yahoo Finance
Mar 17th, 2026
Waters Corporation Q4 results mixed as research tools sector faces 20.9% share price decline

Waters Corporation reported Q4 revenues of $932.4 million, down 45.4% year on year, meeting analysts' expectations. The analytical instruments manufacturer delivered mixed results, with next quarter's revenue guidance exceeding expectations but earnings per share guidance falling short. The research tools and consumables sector reported a satisfactory Q4 overall, with the 10 tracked stocks beating revenue consensus estimates by 1.2%. However, share prices have struggled, declining 20.9% on average since latest earnings results. Founded in 1958, Waters develops analytical instruments, software and consumables for liquid chromatography, mass spectrometry and thermal analysis. CEO Udit Batra highlighted the company achieved high single-digit revenue growth and double-digit adjusted EPS growth in 2025, with momentum expected to continue into 2026.